These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 21606841

  • 1. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
    Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Hamda KB, Najah M, Maatouk F, Rouis M, Slimane MN.
    Coron Artery Dis; 2011; 22(6):388-93. PubMed ID: 21606841
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [Abstract] [Full Text] [Related]

  • 3. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
    Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.
    Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
    [Abstract] [Full Text] [Related]

  • 4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [Abstract] [Full Text] [Related]

  • 5. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW.
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, Cokkinos DV.
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [Abstract] [Full Text] [Related]

  • 7. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
    Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I.
    Clin Chim Acta; 2012 Jan 18; 413(1-2):113-20. PubMed ID: 21963461
    [Abstract] [Full Text] [Related]

  • 8. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
    Sun T, Gao Y, Tan W, Ma S, Zhang X, Wang Y, Zhang Q, Guo Y, Zhao D, Zeng C, Lin D.
    Clin Cancer Res; 2006 Dec 01; 12(23):7009-17. PubMed ID: 17145822
    [Abstract] [Full Text] [Related]

  • 9. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.
    Med Sci Monit; 2008 Oct 01; 14(10):CR536-42. PubMed ID: 18830194
    [Abstract] [Full Text] [Related]

  • 10. Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease.
    Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE.
    Thromb Res; 2006 Oct 01; 118(6):679-83. PubMed ID: 16405973
    [Abstract] [Full Text] [Related]

  • 11. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J.
    Matrix Biol; 2004 Jan 01; 22(7):585-91. PubMed ID: 14996438
    [Abstract] [Full Text] [Related]

  • 12. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction.
    Pearce E, Tregouet DA, Samnegård A, Morgan AR, Cox C, Hamsten A, Eriksson P, Ye S.
    Circ Res; 2005 Nov 11; 97(10):1070-6. PubMed ID: 16210545
    [Abstract] [Full Text] [Related]

  • 13. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
    Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC.
    Carcinogenesis; 2006 May 11; 27(5):1024-9. PubMed ID: 16311244
    [Abstract] [Full Text] [Related]

  • 14. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.
    Weng CJ, Chen MK, Lin CW, Chung TT, Yang SF.
    Ann Surg Oncol; 2012 Jul 11; 19 Suppl 3():S319-27. PubMed ID: 21512861
    [Abstract] [Full Text] [Related]

  • 15. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
    Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP.
    J Clin Periodontol; 2006 Oct 11; 33(10):699-703. PubMed ID: 16899023
    [Abstract] [Full Text] [Related]

  • 16. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J, Sliwińska A, Przybyłowska K, Sliwiński T, Kasznicki J, Zurawska-Klis M, Kosmalski M, Majsterek I.
    Kardiol Pol; 2008 Oct 11; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [Abstract] [Full Text] [Related]

  • 17. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
    Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L, AtheroGene Investigators.
    Circulation; 2003 Apr 01; 107(12):1579-85. PubMed ID: 12668489
    [Abstract] [Full Text] [Related]

  • 18. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.
    Alp E, Menevse S, Tulmac M, Yilmaz A, Yalcin R, Cengel A.
    Genet Test Mol Biomarkers; 2011 Apr 01; 15(4):193-202. PubMed ID: 21142815
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischemic stroke in a Tunisian population.
    Chehaibi K, Hrira MY, Nouira S, Maatouk F, Ben Hamda K, Slimane MN.
    J Neurol Sci; 2014 Jul 15; 342(1-2):107-13. PubMed ID: 24834994
    [Abstract] [Full Text] [Related]

  • 20. Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells.
    Pearce EG, Laxton RC, Pereira AC, Ye S.
    Mol Cancer Res; 2007 Mar 15; 5(3):221-7. PubMed ID: 17339606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.